Kevin J. Anderson, Ph.D.

Postdoctoral Associate

Integrates biomechanical and genomic approaches towards the analysis of brain tumor heterogeneity and disease evolution.

Visit The Verhaak Lab

Contact me at: 860-837-2474

Connect with me:

About Kevin J. Anderson, Ph.D.

Dr. Anderson received his Ph.D. in Biomedical Engineering from Cornell University. For his thesis research he adapted a multiscale numerical simulation towards the analysis of the initial behavior of circulating tumor cell aggregates interacting with activated endothelium. Previously, he received his B.S. in Biomedical Engineering at the University of Alabama at Birmingham.

Download CV

Education and experience

Education

The Jackson Laboratory
Postdoctoral fellow
Adv: Dr. Roel Verhaak
2017-present

Cornell University
Ph.D., Biomedical Engineering
Adv: Dr. Michael King
2011-2017

University of Alabama at Birmingham
B.S., Biomedical Engineering
2007-2011

Experience

Vanderbilt University
Postdoctoral Research Scholar
2017

Cornell University
Graduate Research Assistant
2011-2017

Selected Publications

Anderson KJ, de Guillebon A, Hughes AD, Wang W, King MR. Effect of circulating tumor cell aggregate configuration on hemodynamic transport and wall contact. Math Biosci 294(Dec):181-194, 2017.

View full list of publications

Research HighlightOctober 11, 2018
Stuck in a dangerous cycle
Paper provides important insight for B-cell lymphomagenesis from mouse models to human disease.
Search MagazineOctober 09, 2018
Of mighty mice and men
Pioneering scientist Se-Jin Lee, a leader in the study of muscle development, moves his groundbreaking research program to JAX.
Press ReleaseOctober 02, 2018
Addiction: The microbiome link
The National Institute on Drug Abuse has made a $4M grant to JAX scientists to explore the roles of the microbiome and genetics in substance use disorders.
Blog PostSeptember 25, 2018
American Cancer Society colon cancer screening guidelines
Could early colorectal cancer screening recommended by the American Cancer Society identify more people at high risk for hereditary cancer?
- Colon and Rectal Cancer
- Cancer

Tech CornerOctober 11, 2018
Precision medicine and making sense of data
JAX professor calls for concerted effort to align data across patients and systems with comparable and consistent formats and contextual meaning.
Press ReleaseOctober 09, 2018
Advancing therapeutic gene editing
NIH awards $3.5M to JAX under multi-institution Somatic Cell Genome Editing program.
Press ReleaseSeptember 25, 2018
Brain cancer’s lethal differences: tracking extra DNA
Postdoctoral Associate Eunhee Yi has been awarded a $100,000 fellowship from the American Brain Tumor Association to discover how glioblastoma becomes so aggressive.
Press ReleaseSeptember 21, 2018
New way to target advanced breast cancers
New research shows that a cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.